decisionhealth Newsletters, Coder Pink Sheets - 2007 Issue 12 (December)
ASC final rule: Fee increases for ophthalmology ASCs
Subscribe or sign in to view the full article.
Article Overview
This article explains a Medicare ASC final rule and its impact on ophthalmology practices and ambulatory surgical centers. It focuses on the expansion of procedures allowed in ASCs, the multi-year fee transition, and areas of concern involving office-rate limitations, overnight stay policy, unlisted procedures, implants, devices, and drugs or biologics. It is relevant to ophthalmologists, ASC administrators, and medical coders who need to understand the scope of the payment changes and related Medicare guidance.
Why This Topic Matters
The rule changes which ophthalmic procedures may be performed in ASCs and how those services are paid over time, which can affect site-of-service decisions, ASC viability, and beneficiary cost-sharing. It also highlights payment policy issues that can influence whether certain procedures remain financially practical in the ASC setting.
Article Sections
-
Fee schedule overview and ASC expansion
Introduces the Medicare ASC final rule and the broader expansion of procedures eligible for ASC payment. Summarizes the general direction of payment changes for ophthalmology over the transition period.
-
Selected ophthalmology procedures and payment changes
Presents a table of commonly performed ophthalmology procedures with ASC payment amounts across multiple years. Highlights the broad categories of services affected by the final rule.
-
Concerns with the final rule
Describes policy areas that raised concerns for ophthalmology ASCs, including overnight-stay language, unlisted procedures, and device-related payment issues. Also notes broader operational and reimbursement implications.
-
Devices and biologics
Covers how the rule treats drugs, biologics, and tissue-related costs in ASCs compared with hospital outpatient settings. Notes the general direction of payment policy for these items.
What You Will Learn
- How the Medicare ASC final rule affects ophthalmology services
- What kinds of ophthalmic procedures gained ASC eligibility
- How the payment system changes over the transition period
- Which policy areas created concern for ophthalmology ASCs
- How device, tissue, drug, and biologic costs are addressed in the rule
Who Should Read This
- Ophthalmologists
- ASC administrators
- Medical coders
- Revenue cycle staff
- Healthcare reimbursement professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com